Ultrasound contrast agents: A promising future

Radiologic Clinics of North America

Volumn 39, Issue 3, 2001, Pages 399-414

  Robbin, Michelle L ^b  

^a UNIVERSITY OF ALABAMA HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUNEX; CONTRAST MEDIUM; FLUOROCARBON; FS 069; NC 100100; PERFLUOROOCTYL BROMIDE; PERFLUTREN; SHU 508; SONOVUE; UNCLASSIFIED DRUG;

AERATION; ARTIFACT; BUDD CHIARI SYNDROME; CANCER CHEMOTHERAPY; CAROTID ARTERY; CONTRAST ENHANCEMENT; DOPPLER ECHOGRAPHY; ECHOGRAPHY; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY CYST; KIDNEY TRANSPLANTATION; KIDNEY TUMOR; LIVER TRANSPLANTATION; LIVER TUMOR; MICROENCAPSULATION; PERIPHERAL VASCULAR SYSTEM; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PSEUDOTUMOR; REVIEW; TECHNIQUE; ULTRASOUND SCANNER;

EID: 0034900905     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-8389(05)70288-8     Document Type: Article

References (53)

1. Noninvasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent
2. Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion: Preliminary experience
3. Assessment of renal blood flow with contrast ultrasonography
4. Ultrasound contrast agents
5. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: Early experience
6. The small (< 3.0 cm) renal parenchymal tumor: Detection, diagnosis, and controversies
7. Overview of echo-enhanced vascular ultrasound imaging for clinical diagnosis in neurosonology
8. Hepatic artery stenosis and thrombosis in transplant recipients: Doppler diagnosis with resistive index and systolic acceleration time
9. Color Doppler ultrasound of liver lesions: Signal enhancement after intravenous injection of the ultrasound contrast agent Levovist®
10. Artifacts in ultrasonic contrast agent studies
11. Reliability and validity of noninvasive imaging of internal carotid artery pseudo-occlusion
12. Evaluation of bleeding sites with a tissue-specific sonographic contrast agent: Preliminary experiences
13. Ultrasound contrast agents: A review
14. Wishing won't make it so: Duplex Doppler sonography in the evaluation of renal transplant dysfunction
15. Enhanced detection of blood flow in the normal canine prostate using an ultrasound contrast agent
16. Current status of imaging indeterminate renal masses
17. Effects of a microbubble contrast agent on breast tumors: Computer-assisted quantitative assessment with color Doppler US - Early experience
18. Duplex Doppler sonography in renal allografts: The significance of reversed flow in diastole
19. Microbubble contrast agent for color Doppler US: Effect on breast masses - Work in progress
20. Hepatocellular carcinoma: Power Doppler US with a contrast agent - Preliminary results
21. Contrast-enhanced power Doppler sonography for differentiation of cystic renal lesions: Preliminary study
22. Limitations of characterization of hepatic hemangiomas using a sonographic contrast agent (Levovist®) and power Doppler ultrasonography
23. Ultrasound contrast agents in liver imaging
24. Doppler sonographic enhancement of hepatic hemangiomas and hepatocellular carcinomas after perflenapent emulsion: Preliminary study
25. Microbubble fluid dynamics of echo-contrast
26. Clinical experience with sonographic contrast agents
27. Effect of US contrast agents on spectral velocities: In vitro evaluation
28. Ultrasound of focal hepatic lesions
29. Contrast-enhancement transcranial imaging: Results of an American phase-two study
30. Renal transplant rejection: Limited value of duplex Doppler sonography
31. Evaluation of renal transplant dysfunction by duplex Doppler sonography: A prospective study and review of the literature
32. An investigation of the relationship between ultrasound echo enhancement and Doppler frequency shift using a pulsatile arterial flow phantom
33. Use of Doppler sonography for revealing hepatic artery stenosis in liver transplant recipients
34. Comparison of transcranial power Doppler and contrast-enhanced color-coded sonography in the identification of intracranial arteries
35. Transrectal ultrasound microbubble contrast angiography of the prostate
36. Imaging in the preoperative evaluation of adult liver-transplant candidates: Goals, merits of various procedures, and recommendations
37. The promise of sonographic contrast agents in the kidney
38. Perflenapent emulsion: A US contrast agent for diagnostic radiology: Multicenter, double-blind comparison with a placebo
39. The potential role of ultrasound contrast agents in the liver
40. Speckle decorrelation flow measurement with B-mode US of contrast agent flow in a phantom and in rabbit kidney
41. Sonographic detection of acute parenchymal injury in an experimental porcine model of renal hemorrhage: Gray-scale imaging using a sonographic contrast agent
42. Detection of hepatocellular carcinoma in cirrhotic patients: Sensitivity of CT and ultrasonography
43. Characteristics and clinical value of an intravenous echo-enhancement agent in evaluation of high-grade internal carotid stenosis
44. Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply located hepatocellular carcinoma
45. Doppler evaluation of the portal vein: Effects of intravenous Dodecafluoropentane
46. Color Doppler sonography in early renal transplantation follow-up: Resistive index measurements versus power Doppler sonography
47. Echo-enhanced Doppler sonography in the evaluation of transjugular intrahepatic portosystemic shunts: Clinical application of a new transpulmonary US contrast agent
48. Acoustically active lipospheres containing paclitaxel: A new therapeutic ultrasound contrast agent
49. In vitro studies of a new thrombus-specific ultrasound contrast agent
50. Harmonic hepatic US with microbubble contrast agent: Initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis